VivoSeq
Other

Hysteroscopy

4

Pipeline Programs↗

5

Active Trials↗

3

Companies Involved↗

Hysteroscopy is an early-stage landscape with 4 programs across 3 companies. The most active players are Acacia Pharma Ltd, AbbVie, Fresenius Kabi Oncology Ltd.. 4 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

11/100

Mech. Concentration

50/100

Completion Rate

96/100

Attrition Rate

2/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Acacia Pharma Ltd

1 program

ApprovedAbbVie logo

AbbVie

1 program

ApprovedF

Fresenius Kabi Oncology Ltd.

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved4

Remimazolam

Acacia Pharma Ltd

Flumazenil

Conrado Roberto Hoffmann Filho

Sevoflurane

AbbVie

Propofol

Fresenius Kabi Oncology Ltd.

Analysis

Trial Status

45

clinical trials

Completed22 · 49%
Unknown status17 · 38%
Not yet recruiting4 · 9%
Recruiting1 · 2%
Withdrawn1 · 2%

Clinical Trials

Trial Activity

45 trials

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Recruiting·IIcahn School of Medicine at Mount Sinai·Phase 1·NCT06653400·60 enrolled
Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy
Not yet recruiting·—·N/A·NCT06413862·188 enrolled
Methoxyflurane for Analgesia During Hysteroscopy
Not yet recruiting·—·N/A·NCT06899724·54 enrolled
Assessment of Hysteroscopy Skills in an International Multicenter Trial - Gathering Validity Evidence for a Hysteroscopy Assessment Tool
Not yet recruiting·OOdense University Hospital·N/A·NCT07672288·24 enrolled
Remimazolam With Planned Flumazenil Reversal Versus Sevoflurane-based Balanced Anesthesia for Hysteroscopic Day Surgery: A Randomized Controlled Trial
Not yet recruiting·CChung-Ang University Gwangmyeong Hospital·Approved·NCT07663877·124 enrolled
Optimum Misoprostol Dose Prior to Office Hysteroscopy
Completed·—·Phase 3·NCT01612065·132 enrolled
Optimal Timing of Misoprostol Administration Prior to Office Hysteroscopy
Completed·—·Phase 2·NCT02316301·120 enrolled
Pharmacological Preparation of the Cervix for Hysteroscopy
Completed·JJagiellonian University·N/A·NCT05783479·96 enrolled
Oral Misoprostol for Cervical Priming Before Hysteroscopy
Completed·SSaint-Joseph University·N/A·NCT02159911·84 enrolled
Misoprostol Administration Before Operative Hysteroscopy
Completed·—·Phase 3·NCT01805115·120 enrolled
Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients
Completed·—·Phase 4·NCT04044079·150 enrolled
Comparison Between Two Different Distention Medium in Diagnostic Hysteroscopy
Completed·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT02958722·2,000 enrolled
Misoprostol Versus Uterine Striating by Bladder Filling for Pain Relief During Office Hysteroscopy
Completed·—·Phase 2·NCT02328495·76 enrolled
Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial
Completed·UUllevaal University Hospital·Phase 3·NCT00572819·100 enrolled
Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy
Completed·—·Phase 2·NCT02068209·140 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)